Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
123
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Lymphoma 2016 NCI 5R01CA154739-05 Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics CLEVELAND, JOHN H. LEE MOFFITT CANCER CTR & RES INST FL $598,617
Lymphoma 2016 NCI 1K22CA197014-01 Analysis and Therapeutic Targeting Non-proteolytic Protein Ubiquitination in Diffuse Large B Cell Lymphoma YANG, YIBIN RESEARCH INST OF FOX CHASE CAN CTR PA $194,616
Lymphoma 2016 NIAID 5R01AI105114-03 Viral Interface with an Interferon-Induced Gene REICH, NANCY STATE UNIVERSITY NEW YORK STONY BROOK NY $463,541
Lymphoma 2016 NIAID 5R01AI072194-07 Elucidation of Immunoglobulin Class Switch Recombination CHAUDHURI, JAYANTA SLOAN-KETTERING INST CAN RESEARCH NY $439,750
Lymphoma 2016 NIAID 5R21AI111125-02 Role of PRMT5 in HTLV-1 transformation and disease GREEN, PATRICK OHIO STATE UNIVERSITY OH $231,000
Lymphoma 2016 NIAID 5R01AI114557-02 Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection WANG, FREDERICK BRIGHAM AND WOMEN'S HOSPITAL MA $612,662
Lymphoma 2016 NIAID 5R01AI114556-02 Targeting Fnip1 to disrupt B cell development, metabolism, and transformation IRITANI, BRIAN UNIVERSITY OF WASHINGTON WA $395,376
Lymphoma 2016 NCI 5R01CA182461-03 Defining the impact of clonal evolution on chronic lymphocytic leukemia WU, CATHERINE DANA-FARBER CANCER INST MA $362,378
Lymphoma 2016 NIDCR 4R01DE022291-05 KSHV infection of human tonsillar B cells KEDES, DEAN UNIVERSITY OF VIRGINIA VA $385,000
Lymphoma 2016 NCI 4R37CA076584-18 F-box proteins: deregulated cell cycle control and proteolysis in cancer PAGANO, MICHELE NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $446,546
Lymphoma 2016 NCI 4R01CA085180-15 Epstein-Barr Virus LMP1-Mediated Oncogenecity KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $762,316
Lymphoma 2016 NCI 4R01CA164178-04 A novel NKG2D-specific BiTE cancer immunotherapy SENTMAN, CHARLES DARTMOUTH COLLEGE NH $336,150
Lymphoma 2016 NCI 5R21CA191726-02 Therapeutic targeting of the B-cell lymphoma associated mutation MYD88-L265P SNYDER, GREG UNIVERSITY OF MARYLAND BALTIMORE MD $179,403
Lymphoma 2016 NCI 4P30CA006516-51 6047 Lymphoma and Myeloma SHIPP, MARGARET DANA-FARBER CANCER INST MA $93,216
Lymphoma 2016 NCI 5R01CA184187-02 DNA-PKCS Phosphorylation in DNA Repair and Chromosomal Translocations ZHA, SHAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $366,000
Lymphoma 2016 NCI 5R21CA184707-02 Genomic instability mediated via differential DNA repair mechanisms in B cells WANG, JING UNIVERSITY OF COLORADO DENVER CO $202,928
Lymphoma 2016 NCI 4R01CA134674-07 GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA CAMP, NICOLA UNIVERSITY OF UTAH UT $557,717
Lymphoma 2016 NCI 4R01CA166450-04 Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia RAO, DINESH UNIVERSITY OF CALIFORNIA LOS ANGELES CA $319,550
Lymphoma 2016 NCI 4R01CA168482-04 HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma MARTINEZ-MAZA, OTONIEL UNIVERSITY OF CALIFORNIA LOS ANGELES CA $319,550
Lymphoma 2016 NCI 4F31CA183569-03 The Role of ATF4 in Promoting c-Myc Induced Lymphomagenesis TAMEIRE, FEVEN UNIVERSITY OF PENNSYLVANIA PA $43,120
Lymphoma 2016 NCI 4R01CA172492-04 Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma PASQUALUCCI, LAURA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $332,000
Lymphoma 2016 NIAID 4R01AI106393-04 BH3-only protein targeting by HHV-8 NICHOLAS, JOHN JOHNS HOPKINS UNIVERSITY MD $405,000
Lymphoma 2016 NCI 5P30CA008748-50 7551 Monoclonal Antibody WEIS-GARCIA, FRANCES SLOAN-KETTERING INST CAN RESEARCH NY $282,755
Lymphoma 2016 NIGMS 5R01GM111741-02 High-throughput informatics for antibodies MACCARTHY, THOMAS STATE UNIVERSITY NEW YORK STONY BROOK NY $266,488
Lymphoma 2016 NCI 5K22CA184308-02 Dissecting Genetic and Epigenetic variation in the Cancer Regulome HODGES, EMILY VANDERBILT UNIVERSITY TN $157,854
Lymphoma 2016 NCI 4R01CA165206-05 CD19 Directed CAR Therapy JUNE, CARL UNIVERSITY OF PENNSYLVANIA PA $237,659
Lymphoma 2016 NIAID 5R01AI108407-02 Role of MHV68 miRNAs in latencyand pathogenesis TIBBETTS, SCOTT UNIVERSITY OF FLORIDA FL $390,515
Lymphoma 2016 NCI 4R01CA172582-04 Alpha Radioimmunotherapy for Lymphoma Treatment SANDMAIER, BRENDA FRED HUTCHINSON CANCER RESEARCH CENTER WA $634,846
Lymphoma 2016 NCI 5R01CA183444-03 Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies BYRD, JOHN OHIO STATE UNIVERSITY OH $536,570
Lymphoma 2016 NCI 4P50CA094056-16 7927 Imaging NFkB Activation in HTLV Lymphoma RATNER, LEE WASHINGTON UNIVERSITY MO $101,413
Lymphoma 2016 NCI 5R01CA172724-02 Novel Strategies to Target Leukemia-Stromal Interactions HUANG, PENG UNIVERSITY OF TX MD ANDERSON CAN CTR TX $366,000
Lymphoma 2016 NCI 1R35CA200422-01 Molecular Basis of KSHV oncogenesis JUNG, JAE UNIVERSITY OF SOUTHERN CALIFORNIA CA $652,549
Lymphoma 2016 NIAID 5R01AI106676-03 Epstein Barr virus antisense transcription FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $376,250
Lymphoma 2016 NIAID 4R01AI018757-34 Host Immunity to EBV Infection in Vitro and in Vivo THORLEY-LAWSON, DAVID TUFTS UNIVERSITY BOSTON MA $412,500
Lymphoma 2016 NIDCR 5K99DE024969-02 Factors Influencing KSHV Infection and Spread within the Oral Cavity TOTONCHY, JENNIFER WEILL MEDICAL COLL OF CORNELL UNIV NY $123,050
Lymphoma 2016 NIAID 5R21AI112602-02 Chromosome fragility and translocations in lymphocytes ROBBIANI, DAVIDE ROCKEFELLER UNIVERSITY NY $254,250
Lymphoma 2016 NCI 1P50CA192937-01A1 7606 Administrative Core YOUNES, ANAS SLOAN-KETTERING INST CAN RESEARCH NY $245,228
Lymphoma 2016 NCI 1P50CA192937-01A1 7607 BIOSPECIMENS CORE DOGAN, AHMET SLOAN-KETTERING INST CAN RESEARCH NY $221,023
Lymphoma 2016 NCI 1P50CA192937-01A1 7608 BIOSTATISTICS AND BIOINFORMATICS CORE SESHAN, VENKATRAMAN SLOAN-KETTERING INST CAN RESEARCH NY $182,764
Lymphoma 2016 NCI 1P50CA192937-01A1 7609 DEVELOPMENTAL RESEARCH PROGRAM YOUNES, ANAS SLOAN-KETTERING INST CAN RESEARCH NY $224,278
Lymphoma 2016 NCI 1P50CA192937-01A1 7611 Development of Mechanism-Based Therapy For Myc+/Bcl2+ Diffuse Large B Cell Lymphoma YOUNES, ANAS SLOAN-KETTERING INST CAN RESEARCH NY $275,717
Lymphoma 2016 NCI 1P50CA192937-01A1 7612 Autologous CD19 Targeted 19-28z+ Tcells for the Treatment of Relapsed Diffuse Large B cell Lymphoma in Transplant Ineligible Elderly Patients BRENTJENS, RENIER SLOAN-KETTERING INST CAN RESEARCH NY $313,752
Lymphoma 2016 NCI 1P50CA192937-01A1 7613 Translating Stress Response Targeted Therapy for B-Cell Lymphomas CHIOSIS, GABRIELA SLOAN-KETTERING INST CAN RESEARCH NY $317,872
Lymphoma 2016 NCI 1P50CA192937-01A1 7614 Targeting Acetyltransferase Gene Inactivation in Diffuse Large B Cell Lymphoma ZELENETZ, ANDREW SLOAN-KETTERING INST CAN RESEARCH NY $381,366
Lymphoma 2016 NCI 4R01CA165469-04 Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia BONDADA, SUBBARAO UNIVERSITY OF KENTUCKY KY $381,420
Lymphoma 2016 NCI 4R01CA091791-14 Reactivation of Kaposi's Sarcoma-Associated Herpesvirus SUN, REN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $284,547
Lymphoma 2016 NCI 5R01CA180758-03 KSHV interactions with host inflammasome components CHANDRAN, BALA ROSALIND FRANKLIN UNIV OF MEDICINE & SCI IL $320,588
Lymphoma 2016 NIAID 5R37AI037526-22 Class Switch Recombination in B Lymphocytes NUSSENZWEIG, MICHEL ROCKEFELLER UNIVERSITY NY $423,750
Lymphoma 2016 NCI 5R01CA076167-13 Genetic Analysis of Myeloproliferative Disease COWELL, JOHN GEORGIA REGENTS UNIVERSITY GA $307,800
Lymphoma 2016 NCI 5R01CA180813-03 Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs GOTTWEIN, EVA NORTHWESTERN UNIVERSITY AT CHICAGO IL $320,588
Lymphoma 2016 NCI 2P30CA016520-40 8007 Hematologic Malignancies Research Program STADTMAUER, EDWARD UNIVERSITY OF PENNSYLVANIA PA $72,887
Lymphoma 2016 NCI 2P30CA016520-40 4005 Melanoma and Cutaneous Malignancies Research Program SCHUCHTER, LYNN UNIVERSITY OF PENNSYLVANIA PA $72,887
Lymphoma 2016 NCI 4R01CA119917-09 Studying the role of KSHV-encoded miRNAs RENNE, ROLF UNIVERSITY OF FLORIDA FL $301,913
Lymphoma 2016 NCI 4R01CA157660-05 The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis KLEIN, ULF COLUMBIA UNIVERSITY HEALTH SCIENCES NY $331,433
Lymphoma 2016 NCI 2P30CA014089-41 8288 Molecular Genetics Research Program (Project-001) LIEBER, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $35,512
Lymphoma 2016 NCI 2P30CA016086-40 8627 EARLY PHASE CLINICAL RESEARCH SUPPORT (Core 020) DEES, ELIZABETH UNIV OF NORTH CAROLINA CHAPEL HILL NC $283,606
Lymphoma 2016 NIEHS 4R01ES021832-04 Endocrine disrupter modulation of SXR in development and lymphomagenesis BLUMBERG, BRUCE UNIVERSITY OF CALIFORNIA-IRVINE CA $422,908
Lymphoma 2016 NCI 4R01CA164605-05 Hdac3 as a therapeutic target in BCL6-dependent lymphoma HIEBERT, SCOTT VANDERBILT UNIVERSITY TN $403,135
Lymphoma 2016 NCI 4R01CA166144-05 Development of Therapeutic CD59 inhibitor for treating B-cell malignancies QIN, XUEBIN TEMPLE UNIV OF THE COMMONWEALTH PA $327,938
Lymphoma 2016 NCI 4UM1CA173642-04 Women's Health Initiative Cancer Survivor Cohort ANDERSON, GARNET FRED HUTCHINSON CANCER RESEARCH CENTER WA $2,396,733
Lymphoma 2016 NCI 5R01CA190384-02 The genomic pathogenesis of Follicular Lymphoma MALEK, SAMI UNIVERSITY OF MICHIGAN MI $541,994
Lymphoma 2016 NIAID 4U01AI104342-04 Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children ESQUIVEL, CARLOS STANFORD UNIVERSITY CA $1,363,549
Lymphoma 2016 NCI 4P01CA094237-14 7520 VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $295,517
Lymphoma 2016 NCI 5R01CA179363-03 Molecular signature of inflammation MALARKANNAN, SUBRAMANIAM MEDICAL COLLEGE OF WISCONSIN WI $322,594
Lymphoma 2016 NIDCR 5R01DE025208-02 KSHV latent infection replication KAYE, KENNETH BRIGHAM AND WOMEN'S HOSPITAL MA $443,750
Lymphoma 2016 NIGMS 1K99GM117302-01 A novel role for 53BP1 independent of damage that controls chromatin structure PEREIRA DA ROCHA, PEDRO NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $90,000
Lymphoma 2016 NCI 5R01CA075922-20 Rhesus HHV-8 homologue in AIDS-related malignancies WONG, SCOTT OREGON HEALTH & SCIENCE UNIVERSITY OR $748,902
Lymphoma 2016 NCI 5R01CA187299-02 Epigenetic Gene Regulation by JAK1 Kinase in Diffuse Large B-Cell Lymphoma RUI, LIXIN UNIVERSITY OF WISCONSIN-MADISON WI $349,988
Lymphoma 2016 NCI 5F31CA192835-02 Intratumoral Heterogeneity and Tumor Evolution in Lymphoma KASTENHUBER, EDWARD SLOAN-KETTERING INST CAN RESEARCH NY $43,576
Lymphoma 2016 NIAID 5R01AI110328-03 Viral Long Noncoding RNA Functions in Epstein-Barr Virus Infection SAMPLE, JEFFERY PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $378,297
Lymphoma 2016 NCI 4R01CA170023-04 Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $393,163
Lymphoma 2016 NCI 5R01CA184384-03 Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging FELSHER, DEAN STANFORD UNIVERSITY CA $528,101
Lymphoma 2016 NIAID 1R21AI122068-01 Antibody-based prophylactic EBV vaccine SNAPPER, CLIFFORD HENRY M. JACKSON FDN FOR THE ADV MIL/MED MD $231,012
Lymphoma 2016 NCI 5K22CA188106-02 Characterization of replication-mediated DNA damage in B lymphocytes BARLOW, JACQUELINE UNIVERSITY OF CALIFORNIA AT DAVIS CA $162,000
Lymphoma 2016 NCI 1R01CA193140-01A1 Targeting the Ig-light chains with CAR-T cells in lymphoid tumors DOTTI, GIANPIETRO UNIV OF NORTH CAROLINA CHAPEL HILL NC $569,255
Lymphoma 2016 NIAID 5U19AI109965-03 5822 Innate Recognition of Human Herpesviruses DAMANIA, BLOSSOM UNIV OF NORTH CAROLINA CHAPEL HILL NC $415,378
Lymphoma 2016 NCI 4R01CA160256-05 Temporal and Spatial Control of V(D)J Recombination DESIDERIO, STEPHEN JOHNS HOPKINS UNIVERSITY MD $336,150
Lymphoma 2016 NCI 4R01CA164152-05 Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis DALLA-FAVERA, RICCARDO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $332,000
Lymphoma 2016 NCI 4R01CA177319-04 The Role of NOTCH1 in the Pathogenesis of CLL. DALLA-FAVERA, RICCARDO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $358,315
Lymphoma 2016 NCI 5R21CA185930-02 Function-blocking anti-ADAM protease antibodies for inhibition of tumorigenesis NIKOLOV, DIMITAR SLOAN-KETTERING INST CAN RESEARCH NY $191,291
Lymphoma 2016 NCI 1R01CA195732-01A1 The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy LICHT, JONATHAN UNIVERSITY OF FLORIDA FL $343,125
Lymphoma 2016 NCI 1R21CA202525-01 Targeting CXCR5 for angioimmunoblastic T-cell lymphoma LOLIS, ELIAS YALE UNIVERSITY CT $212,223
Lymphoma 2016 NCI 5F30CA189433-02 Investigating the function of MTBP in lymphoma PUCCETTI, MATTHEW VANDERBILT UNIVERSITY TN $28,234
Lymphoma 2016 NCI 5R01CA137488-21 Two Compartment Models to Improve Brain Tumor Therapy NEUWELT, EDWARD OREGON HEALTH & SCIENCE UNIVERSITY OR $474,976
Lymphoma 2016 NCI 4R01CA124332-10 Regulation of KSHV infection and replication by MAPK pathways GAO, SHOU-JIANG UNIVERSITY OF SOUTHERN CALIFORNIA CA $304,095
Lymphoma 2016 NCI 1UH2CA202637-01 Smartphone for molecular cancer diagnostic in Africa WEISSLEDER, RALPH MASSACHUSETTS GENERAL HOSPITAL MA $491,375
Lymphoma 2016 NIAID 4R01AI058057-12 Function of the Gamma HV68 M2 Antigen SPECK, SAMUEL EMORY UNIVERSITY GA $385,800
Lymphoma 2016 NCI 4R01CA154674-06 Cotranslational Functions of MTOR JACINTO, ESTELA RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL NJ $328,265
Lymphoma 2016 NCI 5R01CA142698-07 Molecular mechanism and relevance of microRNAs in DSB repair pathway choice CHOWDHURY, DIPANJAN DANA-FARBER CANCER INST MA $409,002
Lymphoma 2016 NHLBI 4R01HL116452-04 The role of the SF3B1 splicing factor in chronic lymphocytic leukemia WU, CATHERINE DANA-FARBER CANCER INST MA $434,621
Lymphoma 2016 NCI 5P01CA174653-03 6841 The Role of CTIP in Lymphocyte Development and Lymphomagenesis ZHA, SHAN COLUMBIA UNIVERSITY NY $364,328
Lymphoma 2016 NCI 5P01CA174653-03 6845 Pathology BHAGAT, GOVIND COLUMBIA UNIVERSITY NY $188,901
Lymphoma 2016 NCI 5U01CA183012-03 Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient ZAIA, JOHN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $106,075
Lymphoma 2016 NCI 4R01CA063417-16 PROLIFERATIVE EFFECTS OF HTLV-1 RATNER, LEE WASHINGTON UNIVERSITY MO $158,641
Lymphoma 2016 NCI 4R01CA113809-10 Role of Missing Metastasis Gene in tumor progression ZHAN, STEVEN UNIVERSITY OF MARYLAND BALTIMORE MD $264,562
Lymphoma 2016 NCI 4R01CA158323-05 Studies of Lymphoma Suppression and DNA Repair DU, CHUNYING UNIVERSITY OF CINCINNATI OH $325,775
Lymphoma 2016 NCI 4R01CA070723-19 Genetic Analysis of EBV's Immortalizing Genes SUGDEN, WILLIAM UNIVERSITY OF WISCONSIN-MADISON WI $291,588
Lymphoma 2016 NCI 4R01CA174462-04 New Models and Treatments for AIDS-related Lymphoma KENNEY, SHANNON UNIVERSITY OF WISCONSIN-MADISON WI $416,873
Lymphoma 2016 NIAID 4R01AI076183-14 Structural and Functional Studies of gp42 and HLA Class 2 in EBV Entry LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY AT CHICAGO IL $507,585
Lymphoma 2016 NCI 5F31CA196209-02 Examining the Role of Rho Kinase in the Pathogenesis of ABC-DLBCL RICKER, EDD WEILL MEDICAL COLL OF CORNELL UNIV NY $43,576
Lymphoma 2016 NIAID 4R01AI101046-05 Intercellular communication in Epstein Barr virus reactivation FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $376,250
Lymphoma 2016 NCI 4R01CA162411-04 Novel monocyte effector function in CLL immune therapy TRIDANDAPANI, SUSHEELA OHIO STATE UNIVERSITY OH $319,550
Lymphoma 2016 NCI 5R01CA192267-02 Monitoring disease progression in follicular lymphoma with next-gen sequencing CARLSON, CHRISTOPHER FRED HUTCHINSON CANCER RESEARCH CENTER WA $691,364
Lymphoma 2016 NCI 4R01CA166219-05 Molecular epidemiology of non-Hodgkin lymphoma prognosis and prevention WANG, SOPHIA BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $561,758
Lymphoma 2016 NCI 4R01CA174794-04 Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation KRULL, KEVIN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $642,665
Lymphoma 2016 NCI 5R21CA195173-02 The genetics of hepatosplenic T cell lymphoma DAVE, SANDEEP DUKE UNIVERSITY NC $180,599
Lymphoma 2016 NCI 5R00CA151827-05 Role of Replication Stress during Myc-dependent Lymphomagenesis DOMINGUEZ-SOLA, DAVID ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $238,992
Lymphoma 2016 NCI 5R01CA167093-06 Myc-directed control of mRNA turnover in lymphopoiesis and lymphomagenesis CLEVELAND, JOHN H. LEE MOFFITT CANCER CTR & RES INST FL $349,638
Lymphoma 2016 NCI 5F30CA183520-02 Targeting CD37 and elucidating its role in B-cell malignancy BECKWITH, KYLE OHIO STATE UNIVERSITY OH $38,671
Lymphoma 2016 NCI 1R01CA194263-01A1 Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders FANG, CAROLYN RESEARCH INST OF FOX CHASE CAN CTR PA $662,485
Lymphoma 2016 NCI 5R01CA193655-02 Defining the Functional Role of Mutations in Diffuse Large B cell Lymphoma DAVE, SANDEEP DUKE UNIVERSITY NC $510,478
Lymphoma 2016 NHLBI 4R01HL116217-04 Engraftment and in vivo selection of HIV-protected stem cells KIEM, HANS-PETER FRED HUTCHINSON CANCER RESEARCH CENTER WA $808,300
Lymphoma 2016 NCI 5R01CA184728-02 Targeting Granzyme B to Separate GVH from GVL Responses CAO, XUEFANG ROSWELL PARK CANCER INSTITUTE CORP NY $401,456
Lymphoma 2016 NCI 4R01CA166325-05 Mechanisms promoting translocations and mature B cell lymphomas WANG, JING UNIVERSITY OF COLORADO DENVER CO $333,570
Lymphoma 2016 NCI 5R01CA188561-02 The Tumor Suppressor Function of Dnmt3a in Chronic Lymphocytic Leukemia OPAVSKY, RENE UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $344,269
Lymphoma 2016 NCI 4R01CA177292-04 Targeted Therapy for Lymphoid Malignancies BYRD, JOHN OHIO STATE UNIVERSITY OH $536,708
Lymphoma 2016 NCI 4R01CA093606-14 Regulation of EBV Latency by EBNA1 LIEBERMAN, PAUL WISTAR INSTITUTE PA $329,956
Lymphoma 2016 NIAID 1R43AI122529-01 CRISPR-based anti-viral therapeutics to eliminate EBV-associated post-transplant lymphoproliferative disease XIONG, XIN AGENOVIR CORPORATION CA $149,972
Lymphoma 2016 NCI 2R44CA153474-02A1 Virus-targeted therapeutic for EBV-Associated Malignancies PERRINE, SUSAN PHOENICIA BIOSCIENCES, INC. MA $472,008
Lymphoma 2016 NCI 7R21CA184352-02 Myc-induced pathways in B cell lymphoma initiation and survival EISCHEN, CHRISTINE THOMAS JEFFERSON UNIVERSITY PA $169,650
Lymphoma 2016 NCI 1F32CA203217-01 Role of branched-chain amino catabolism in lymphopoiesis and lymphomagenesis FERNANDEZ, MARIO H. LEE MOFFITT CANCER CTR & RES INST FL $58,002
Lymphoma 2016 NCI 1F30CA203292-01 Chromatin dysregulation generated by recurrent point mutation in histone methyltransferase, MMSET, drives progression of lymphoid malignancies SWAROOP, ALOK UNIVERSITY OF FLORIDA FL $37,411
Lymphoma 2016 NCI 5R01CA182947-03 Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells FARAG, SHERIF INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $321,933
Lymphoma 2016 NCI 5R44CA192576-02 A Phase IIa Study of rHuIL-12 as an Immunotherapy and Radiomitigator for CTCL Patients Receiving Radiotherapy BASILE, LENA NEUMEDICINES, INC. CA $417,175
Lymphoma 2016 NCI 2R13CA124293-09 Annual International Primary CNS Lymphoma Collaborative Group Meeting BATCHELOR, TRACY MASSACHUSETTS GENERAL HOSPITAL MA $2,500
Lymphoma 2016 NIAID 5R01AI109644-03 Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di SUN, ZUOMING BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $420,000
Lymphoma 2016 NCI 4R01CA164641-04 Natural Killer Cell Regulation by PRDM1 and IRF4/8 WRIGHT, KENNETH H. LEE MOFFITT CANCER CTR & RES INST FL $314,674
Lymphoma 2016 NCI 5F31CA183551-02 Mechanisms and Function of Suppressed RAG Expression by DNA Double Strand Breaks FISHER, MEGAN UNIVERSITY OF PENNSYLVANIA PA $43,576
Lymphoma 2016 NIAID 1R21AI122670-01 Developing a new model for EBV-mediated T cell diseases PELANDA, ROBERTA UNIVERSITY OF COLORADO DENVER CO $194,375
Lymphoma 2016 NIDCR 1R01DE025804-01 Role of IKK epsilon in KSHV/HHV8 associated malignancies CHAUDHARY, PREET UNIVERSITY OF SOUTHERN CALIFORNIA CA $412,500
Lymphoma 2016 NCI 4K23CA154874-04 Optimization of adoptive immunotherapy with autologous CD20-specific T cells TILL, BRIAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $171,720
Lymphoma 2016 NCI 5R01CA178453-03 Role of MEF2B mutations in lymphomagenesis DALLA-FAVERA, RICCARDO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $443,555
Lymphoma 2016 NCI 5R01CA183876-03 Towards The Chemotherapy-Free Treatment of Follicular Lymphoma WENDEL, HANS-GUIDO SLOAN-KETTERING INST CAN RESEARCH NY $475,801
Lymphoma 2016 NCI 5R01CA184922-03 (PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL WU, CATHERINE DANA-FARBER CANCER INST MA $553,684
Lymphoma 2016 NCI 4R01CA166741-05 Anticancer drug-induced BH3-only protein.Bak interactions KAUFMANN, SCOTT MAYO CLINIC ROCHESTER MN $329,925
Lymphoma 2016 NCI 4R01CA177600-04 Regulation of CARD11 signaling in normal and dysregulated lymphocyte development POMERANTZ, JOEL JOHNS HOPKINS UNIVERSITY MD $336,150
Lymphoma 2016 NCI 5R01CA187415-02 MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma LI, YONG CLEVELAND CLINIC LERNER COM-CWRU OH $439,795
Lymphoma 2016 NCI 5R01CA192928-02 Dual targeting of XPO1 and BTK in B cell malignancies LAPALOMBELLA, ROSA OHIO STATE UNIVERSITY OH $445,083
Lymphoma 2016 NCI 5UM1CA182934-02 The NYU Women's Health Study ZELENIUCH-JACQUOTTE, ANNE NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $742,259
Lymphoma 2016 NCI 4P01CA022443-39 6859 Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus MERTZ, JANET UNIVERSITY OF WISCONSIN-MADISON WI $345,175
Lymphoma 2016 NCI 4P01CA022443-39 6863 miRNA and v-Cdks: Independent Drivers OF EBV and HCMV Replication and Oncogenesi KENNEY, SHANNON UNIVERSITY OF WISCONSIN-MADISON WI $392,338
Lymphoma 2016 NCI 5R01CA186775-03 Development of a Small Molecule Inhibitor for KSHV LANA LIEBERMAN, PAUL WISTAR INSTITUTE PA $394,250
Lymphoma 2016 NIGMS 5R01GM110052-03 Functional roles of lipids in early B cell receptor signaling. VEATCH, SARAH UNIVERSITY OF MICHIGAN MI $288,288
Lymphoma 2016 NCI 5F30CA183263-02 Multifunctional polymeric carriers for the intracellular delivery of protein cancer therapeutics KERN, HANNA UNIVERSITY OF WASHINGTON WA $37,627
Lymphoma 2016 NIAID 4R01AI105000-04 KSHV Lytic DNA Replication and its Control Mechanism VERMA, SUBHASH UNIVERSITY OF NEVADA RENO NV $356,575
Lymphoma 2016 NCI 5R21CA192854-02 The coding genome of HIV-associated plasmablastic lymphomas in South Africa WILLEM, PASCALE WITS HEALTH CONSORTIUM (PTY), LTD SO AFR $182,178
Lymphoma 2016 NIAID 5R21AI119894-02 Analysis of the role of immune deficiency in E2A-/- T cell lymphomagenesis KEE, BARBARA UNIVERSITY OF CHICAGO IL $227,372
Lymphoma 2016 NIAID 5R21AI118606-02 Isolation of Regulators of Immune Cell Behavior POMERANTZ, JOEL JOHNS HOPKINS UNIVERSITY MD $202,500
Lymphoma 2016 NCI 4U01CA168426-05 Systems Biology of Tumor Progression and Drug Resistance CALIFANO, ANDREA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $1,238,106
Lymphoma 2016 NCI 5R01CA188286-02 SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA PAYTON, JACQUELINE WASHINGTON UNIVERSITY MO $348,844
Lymphoma 2016 NCI 5F30CA196082-02 Defining the role of mutant XPO1 in chronic lymphocytic leukemia HING, ZACHARY OHIO STATE UNIVERSITY OH $38,311
Lymphoma 2016 NCI 5R21CA189703-02 Clinicopathological significance of PDLIM2 in HIV/AIDS-related malignancies caused by KSHV QU, ZHAOXIA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $200,970
Lymphoma 2016 NCI 4R01CA129037-09 Replicative Senescence as a Tumor Suppressive Mechanism CHANG, SANDY YALE UNIVERSITY CT $306,860
Lymphoma 2016 NCI 4R01CA159296-05 Novel Immunotherapies for Lymphoid Malignancies BYRD, JOHN OHIO STATE UNIVERSITY OH $316,438
Lymphoma 2016 NCI 5R01CA181699-03 Investigating the roles of lncRNAs in cancer and development VENTURA, ANDREA SLOAN-KETTERING INST CAN RESEARCH NY $427,270
Lymphoma 2016 NCI 5R01CA073507-18 In Vivo Model of Epstein-Barr Virus Latency LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY AT CHICAGO IL $372,677
Lymphoma 2016 NCI 7R01CA170006-05 Microvesicle Dynamics in B-Cell Chronic Lymphocytic Leukemia Tumor Microenvironme GHOSH, ASISH UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $305,069
Lymphoma 2016 NCI 1R21CA200420-01A1 The effect of statins on B cell dysfunction in HIV infection MARTINEZ-MAZA, OTONIEL UNIVERSITY OF CALIFORNIA LOS ANGELES CA $179,988
Lymphoma 2016 NCI 1R01CA196266-01A1 A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL PENICHET, MANUEL UNIVERSITY OF CALIFORNIA LOS ANGELES CA $504,843
Lymphoma 2016 NIAID 4R01AI067968-10 Role and mechanism of action of gamma herpesvirus microRNAs CULLEN, BRYAN DUKE UNIVERSITY NC $392,500
Lymphoma 2016 NCI 1R01CA192970-01A1 Lipoxins and aspirin triggered lipoxins in KSHV latency and pathogenesis SHARMA-WALIA, NEELAM ROSALIND FRANKLIN UNIV OF MEDICINE & SCI IL $356,850
Lymphoma 2016 NIDCR 1R01DE025567-01A1 Atomic structure of Kaposi's sarcoma-associated herpesvirus capsid ZHOU, Z UNIVERSITY OF CALIFORNIA LOS ANGELES CA $385,000
Lymphoma 2016 NCI 5R01CA181319-03 Targeting Stem-Cell Dependent Drug Resistance in Human MCL MCCARTY, NAMI UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $313,723
Lymphoma 2016 NIGMS 4R01GM103843-04 Dissecting Cell Signaling Mediated by Protein-Protein Interactions in Membranes YIN, HANG UNIVERSITY OF COLORADO CO $295,850
Lymphoma 2016 NIGMS 4R01GM107058-04 Role of constitutive androstane receptor in cyclophosphamide-based chemotherapy WANG, HONGBING UNIVERSITY OF MARYLAND BALTIMORE MD $291,650
Lymphoma 2016 NCI 4R01CA047006-29 Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $565,231
Lymphoma 2016 NIGMS 1R35GM118009-01 Site-Specific Recombination in Human Health & Disease LIEBER, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $336,183
Lymphoma 2016 NCI 4P01CA023766-37 6334 Clinical Trials Evaluating Transplant Strategies and Adoptive Cell Therapies to O'REILLY, RICHARD SLOAN-KETTERING INST CAN RESEARCH NY $433,106
Lymphoma 2016 NCI 2R44CA144104-04 Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma KLINGHOFFER, RICHARD PRESAGE BIOSCIENCES, INC. WA $1,053,521
Lymphoma 2016 NCI 5R01CA182905-03 Protein-coding and non-coding RNA biomarkers for early detection of CLL CALIN, GEORGE UNIVERSITY OF TX MD ANDERSON CAN CTR TX $574,442
Lymphoma 2016 NCI 5K24CA184039-03 Molecularly Targeted Therapy for Lymphoma GOPAL, AJAY UNIVERSITY OF WASHINGTON WA $173,074
Lymphoma 2016 NCI 4R01CA085563-14 ROS, Redox Regulation and Novel Targets for Cancer Therapy HUANG, PENG UNIVERSITY OF TX MD ANDERSON CAN CTR TX $233,579
Lymphoma 2016 NCI 4R01CA168558-05 Cyclin requirements in gammaherpesvirus infection and disease VAN DYK, LINDA UNIVERSITY OF COLORADO DENVER CO $308,843
Lymphoma 2016 NCI 5R01CA187040-04 Targeting SIRT1 in Mantle Cell Lymphoma SETO, EDWARD GEORGE WASHINGTON UNIVERSITY DC $213,099
Lymphoma 2016 NHLBI 4U10HL108945-06 Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $160,218
Lymphoma 2016 NHLBI 4U10HL109322-06 The Ohio State Blood and Marrow Transplant Reseach Consortium DEVINE, STEVEN OHIO STATE UNIVERSITY OH $151,193
Lymphoma 2016 NCI 4P30AI027757-29 7315 HIV-Associated Malignancies (HIVAM) HOLMES, KING UNIVERSITY OF WASHINGTON WA $52,079
Lymphoma 2016 NHLBI 4P30AI027757-29 7315 HIV-Associated Malignancies (HIVAM) HOLMES, KING UNIVERSITY OF WASHINGTON WA $37,284
Lymphoma 2016 NIA 4P30AI027757-29 7315 HIV-Associated Malignancies (HIVAM) HOLMES, KING UNIVERSITY OF WASHINGTON WA $2,683
Lymphoma 2016 NIAID 4P30AI027757-29 7315 HIV-Associated Malignancies (HIVAM) HOLMES, KING UNIVERSITY OF WASHINGTON WA $220,407
Lymphoma 2016 NICHD 4P30AI027757-29 7315 HIV-Associated Malignancies (HIVAM) HOLMES, KING UNIVERSITY OF WASHINGTON WA $11,008
Lymphoma 2016 NIDA 4P30AI027757-29 7315 HIV-Associated Malignancies (HIVAM) HOLMES, KING UNIVERSITY OF WASHINGTON WA $26,434
Lymphoma 2016 NIDDK 4P30AI027757-29 7315 HIV-Associated Malignancies (HIVAM) HOLMES, KING UNIVERSITY OF WASHINGTON WA $9,643
Lymphoma 2016 NIGMS 4P30AI027757-29 7315 HIV-Associated Malignancies (HIVAM) HOLMES, KING UNIVERSITY OF WASHINGTON WA $9,643
Lymphoma 2016 NIMH 4P30AI027757-29 7315 HIV-Associated Malignancies (HIVAM) HOLMES, KING UNIVERSITY OF WASHINGTON WA $28,586
Lymphoma 2016 NIAID 4U19AI107810-04 8686 Study of Novel HHV8/KSHV Encoded Genes DAMANIA, BLOSSOM UNIVERSITY OF NORTH CAROLINA SYSTEM NC $401,899
Lymphoma 2016 NCI 5R01CA193624-02 Development of a Novel Inducer for EBV Lytic Therapy LIEBERMAN, PAUL WISTAR INSTITUTE PA $546,954
Lymphoma 2016 NHLBI 4U10HL069233-16 Nebraska/Kansas Blood and Marrow Transplant Research Network VOSE, JULIE UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $154,372
Lymphoma 2016 NCI 5P30CA023100-30 6336 Hematologic Malignancies LIPPMAN, SCOTT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $21,082
Lymphoma 2016 NCI 5R01CA134451-07 Computer-based assessment of tumor microenvironment (TME) in Follicular Lymphoma GURCAN, METIN OHIO STATE UNIVERSITY OH $234,254
Lymphoma 2016 NCI 5U01CA194389-02 Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma ALIZADEH, ARASH STANFORD UNIVERSITY CA $638,806
Lymphoma 2016 NCI 5R01CA193541-02 Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia SHANAFELT, TAIT MAYO CLINIC ROCHESTER MN $511,603
Lymphoma 2016 NCI 4P01CA049605-27 5891 Immune Regulation in HCT NEGRIN, ROBERT STANFORD UNIVERSITY CA $1,151,707
Lymphoma 2016 NCI 4P01CA049605-27 5892 Auto-lmmunotransplantation for Lymphoma LEVY, RONALD STANFORD UNIVERSITY CA $199,530
Lymphoma 2016 NCI 4P01CA049605-27 5893 Memory CDS T Cells for GVL STROBER, SAMUEL STANFORD UNIVERSITY CA $150,528
Lymphoma 2016 NCI 4P01CA049605-27 5894 Improving Graft-versus-Leukemia Alloimmunity against CLL MIKLOS, DAVID STANFORD UNIVERSITY CA $135,776
Lymphoma 2016 NCI 4P01CA049605-27 5897 Administration and Clinical Trial Coordination NEGRIN, ROBERT STANFORD UNIVERSITY CA $258,742
Lymphoma 2016 NCI 4P01CA049605-27 5898 Biostatistics and Data Management LAVORI, PHILIP STANFORD UNIVERSITY CA $186,995
Lymphoma 2016 NCI 4P01CA049605-27 5899 Molecular Diagnostics ZEHNDER, JAMES STANFORD UNIVERSITY CA $239,457
Lymphoma 2016 NCI 4P01CA049605-27 5900 Cell Processing and Sample Distribution Laboratory LOWSKY, ROBERT STANFORD UNIVERSITY CA $377,265
Lymphoma 2016 NCI 4R01CA117794-11 Inhibitors of the Epstein-Barr Virus Entry Machinery JARDETZKY, THEODORE STANFORD UNIVERSITY CA $331,208
Lymphoma 2016 NCI 4R01CA177734-04 Genetic Biomarkers for Risk Assessment of Peripheral T-Cell Lymphomas FELDMAN, ANDREW MAYO CLINIC ROCHESTER MN $329,925
Lymphoma 2016 NCI 2P30CA124435-09 7150 Lymphoma & Leukemia Research Program (Project-007) LEVY, RONALD STANFORD UNIVERSITY CA $36,782
Lymphoma 2016 NCI 2P30CA086862-16 7673 Program 4: Cancer Epidemiology and Population Science LYNCH, CHARLES UNIVERSITY OF IOWA IA $32,573
Lymphoma 2016 NCI 2P01CA019014-37 7901 Project 2 - Membrane trafficking in EBV malignancies: Implication of deubiquitinase UCH-L1 PAGANO, JOSEPH UNIV OF NORTH CAROLINA CHAPEL HILL NC $308,775
Lymphoma 2016 NCI 2P01CA019014-37 7902 Project 3 - Modulation of host cell biology by KSHV DAMANIA, BLOSSOM UNIV OF NORTH CAROLINA CHAPEL HILL NC $308,968
Lymphoma 2016 NCI 2P01CA019014-37 7903 Project 4 - Study of KSHV Carcinogenesis DITTMER, DIRK UNIV OF NORTH CAROLINA CHAPEL HILL NC $303,998
Lymphoma 2016 NCI 1R01CA203721-01 Transforming the diagnosis and care of patients with CTCL using TCR sequencing CLARK, RACHAEL BRIGHAM AND WOMEN'S HOSPITAL MA $742,632
Lymphoma 2016 NCI 1R01CA204621-01 Modulation of Host Cell Exosome Content and Function by EBV LMP1 MECKES, DAVID FLORIDA STATE UNIVERSITY FL $341,849
Lymphoma 2016 NCI 4R01CA164679-05 HVEM-BTLA Pathway in Lymphoma WARE, CARL SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $404,625
Lymphoma 2016 NIAAA 1R01AA024770-01 A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers. FERRARI, PIETRO INTERNATIONAL AGENCY FOR RES ON CANCER FR $513,904
Lymphoma 2016 NIAID 1R01AI123420-01 Targeting Epstein-Barr Virus super-enhancers KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $443,750
Lymphoma 2016 NIAID 1R01AI121300-01A1 Non-coding RNAs in Gammaherpesvirus Infection and Disease VAN DYK, LINDA UNIVERSITY OF COLORADO DENVER CO $385,420
Lymphoma 2016 NCI 5R03CA186223-02 Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments? SALZ, TALYA SLOAN-KETTERING INST CAN RESEARCH NY $87,950
Lymphoma 2016 NCI 5R21CA196348-02 HHV-8 vIRF interactions in the context of infection NICHOLAS, JOHN JOHNS HOPKINS UNIVERSITY MD $211,410
Lymphoma 2016 NIDDK 5K08DK100739-02 The Intraepithelial T cell Response in Celiac Disease HAN, ARNOLD STANFORD UNIVERSITY CA $143,963
Lymphoma 2016 NCI 5R01CA095318-12 Role of B cells in murine gammaherpesvirus 68 SPECK, SAMUEL EMORY UNIVERSITY GA $368,305
Lymphoma 2016 NCI 4P30CA046592-28 6464 Hematologic Malignancies/BMT WICHA, MAX UNIVERSITY OF MICHIGAN MI $335,881
Lymphoma 2016 NCI 5R21CA185875-02 Novel AHCT Regimen for Advanced Hodgkin Lymphoma using Y-90 anti-CD25 with BEAM SMITH, EILEEN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $174,122
Lymphoma 2016 NCI 4K08CA172215-04 The role of GATA-3 in T-cell lymphomas WILCOX, RYAN UNIVERSITY OF MICHIGAN MI $178,618
Lymphoma 2016 NCI 5R01CA189806-03 Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma MOORMANN, ANN UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $576,703
Lymphoma 2016 NCI 5R21CA184469-02 Generation of NKT cells from adult stem cells for adoptive immunotherapy WEBB, TONYA UNIVERSITY OF MARYLAND BALTIMORE MD $166,931
Lymphoma 2016 NCI 4R01CA180150-04 (PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition PETROSKI, MATTHEW SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $558,328
Lymphoma 2016 NCI 4R01CA168477-05 Immune Modulation by Gammaherpesviruses COSCOY, LAURENT UNIVERSITY OF CALIFORNIA BERKELEY CA $234,200
Lymphoma 2016 NCI 4R01CA129974-10 Probing mitochondria and personalizing leukemia therapy with BH3 profiling LETAI, ANTHONY DANA-FARBER CANCER INST MA $315,153
Lymphoma 2016 NCI 4P01CA119070-10 7558 Notch 1 Regulation of T-ALL Genomes ASTER, JON BRIGHAM AND WOMEN'S HOSPITAL MA $292,907
Lymphoma 2016 NCI 5F30CA186458-03 High-resolution analysis of chromatin regulation by the Max network KASINATHAN, SIVAKANTHAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $48,576
Lymphoma 2016 NCI 5F32CA183381-03 c-MYC dependent regulation of de novo lipogenesis in B-cell lymphomagenesis SCOTT, KRISTEN H. LEE MOFFITT CANCER CTR & RES INST FL $59,970
Lymphoma 2016 NCI 4R01CA158402-05 Molecular mechanisms of B cell malignant transformation XIE, PING RUTGERS, THE STATE UNIV OF N.J. NJ $322,456
Lymphoma 2016 NIAID 1R21AI124129-01 Generation of a mouse expressing a photoactivatable Cre recombinase SCHWAB, SUSAN NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $254,250
Lymphoma 2016 NIAID 1R21AI124172-01 Rab7 and NF-kappaB in B cell activation and dysregulation XU, ZHENMING UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $225,338
Lymphoma 2016 NCI 1R21CA206104-01 Mechanisms of c-CBL Regulation in Cutaneous T-Cell Lymphoma (CTCL) WOOD, GARY UNIVERSITY OF WISCONSIN-MADISON WI $199,665
Lymphoma 2016 NIAID 5R21AI119480-02 Structure and function of EBV protein complexes that trigger epithelial cell entry JARDETZKY, THEODORE STANFORD UNIVERSITY CA $195,417
Lymphoma 2016 NCI 5R01CA194547-02 The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma ELEMENTO, OLIVIER WEILL MEDICAL COLL OF CORNELL UNIV NY $530,098
Lymphoma 2016 RMAP 5K01ES025431-04 The role of epigenetic heterogeneity in CLL evolution LANDAU, DAN WEILL MEDICAL COLL OF CORNELL UNIV NY $187,920
Lymphoma 2016 NCI 5K23CA184279-03 Molecular determinants of prognosis in limited-stage follicular lymphoma LOUISSAINT, ABNER MASSACHUSETTS GENERAL HOSPITAL MA $140,263
Lymphoma 2016 NCI 5R01CA197870-02 Improving BTK Directed Therapy for CLL WOYACH, JENNIFER OHIO STATE UNIVERSITY OH $352,275
Lymphoma 2016 NCI 5R21CA199544-02 NKT cells with chimeric antigen receptors WEBB, TONYA UNIVERSITY OF MARYLAND BALTIMORE MD $200,318
Lymphoma 2016 NCI 4R01CA130995-09 Replication Licensing in Genome Stability, Cancer and Aging PRUITT, STEVEN ROSWELL PARK CANCER INSTITUTE CORP NY $324,743
Lymphoma 2016 NIAID 1R01AI124186-01 RNA-directed targeting of AID in immunity and genomic integrity CHAUDHURI, JAYANTA SLOAN-KETTERING INST CAN RESEARCH NY $428,500
Lymphoma 2016 NIAMS 4R01AR063962-04 CTCL immunobiology: lessons from alemtuzumab CLARK, RACHAEL BRIGHAM AND WOMEN'S HOSPITAL MA $366,977
Lymphoma 2016 NCI 5U01CA195568-02 The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study CERHAN, JAMES MAYO CLINIC ROCHESTER MN $2,251,244
Lymphoma 2016 FIC 4K01TW009488-05 Developing a clinical cohort of histopathologically characterized lymphoma GOPAL, SATISH UNIV OF NORTH CAROLINA CHAPEL HILL NC $140,175
Lymphoma 2016 NCI 1R01CA196671-01A1 Mechanisms of Human Lymphoid Chromosomal Translocation LIEBER, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $377,438
Lymphoma 2016 NCI 5F30CA189740-03 Alternative End-Joining in DNA Repair and Chromosomal Translocations KUMAR, VIPUL HARVARD MEDICAL SCHOOL MA $31,559
Lymphoma 2016 NIAID 5R21AI118509-03 TRIM protein-mediated innate immune control of KSHV infection GACK, MICHAELA UNIVERSITY OF CHICAGO IL $237,000
Lymphoma 2016 NCI 5R01CA197945-02 The role of RHOA G17V mutation in peripheral t-cell lymphomas PALOMERO, TERESA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $366,000
Lymphoma 2016 NCI 1R01CA206019-01 Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients COZEN, WENDY UNIVERSITY OF SOUTHERN CALIFORNIA CA $735,600
Lymphoma 2016 NCI 1R21CA195431-01A1 Role of Follicular Dendritic Cells in B lymphoma RICKERT, ROBERT SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $254,475
Lymphoma 2016 NCI 5R01CA163910-05 TARGETING ANTIGEN-INDUCED ER STRESS RESPONSE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEM HU, CHIH-CHI WISTAR INSTITUTE PA $380,146
123


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer